glp-1 효과 새로운 수용체 작용제(Novel GLP-1 receptor agonists) 및 다중 작용제(GLP-1-based multi agonists): GIPR, GCGR, AMLNR 등을 표적으로 하는 구조 기반으로, 체중 감소, 인슐린 감수성 증가, 염증 억제 등을 포함한 대사질환 치료 Glucagon like peptide-1 (GLP-1) 수용체

N., Terterov, I

Phase 3 data from SYNCHRONIZE-1 and SYNCHRONIZE-2, which run for 76 weeks, will provide the first truly comparable duration endpoints

JAMA network open , 7 (6), e2416775-e2416775

Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics

GPx, on the other hand, is an antioxidant enzyme that uses glutathione to neutralise free radicals and other oxidising agents that can damage liver cells

Previous reports on rats have demonstrated that the response of Se-GSH-Px to organic selenium could be dependent upon the dietary provision of vitamin B6 (Yasumoto et al., 1979) (Figure 6)